BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7001056)

  • 1. Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.
    Alexander MR; Dull WL; Kasik JE
    JAMA; 1980 Nov; 244(20):2286-90. PubMed ID: 7001056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease.
    Dull WL; Alexander MR; Sadoul P; Woolson RF
    Am Rev Respir Dis; 1982 Oct; 126(4):656-9. PubMed ID: 6751178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoproterenol challenge during placebo and oral theophylline therapy in chronic obstructive pulmonary disease.
    Dull WL; Alexander MR; Kasik JE
    Am Rev Respir Dis; 1981 Mar; 123(3):340-2. PubMed ID: 7224346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.
    Murciano D; Auclair MH; Pariente R; Aubier M
    N Engl J Med; 1989 Jun; 320(23):1521-5. PubMed ID: 2498658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.
    Taylor DR; Buick B; Kinney C; Lowry RC; McDevitt DG
    Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking.
    Jenne JW; Siever JR; Druz WS; Solano JV; Cohen SM; Sharp JT
    Am Rev Respir Dis; 1984 Oct; 130(4):600-5. PubMed ID: 6486559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term therapy with sustained-release theophylline.
    Myhre KI; Arnulf V; Walstad RA
    Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of theophylline and ipratropium on cognition in elderly patients with chronic obstructive pulmonary disease.
    Ramsdell JW; Henderson S; Renvall MJ; Salmon DP; Ferguson P
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):335-40. PubMed ID: 8612115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary disease.
    Newman D; Tamir J; Speedy L; Newman JP; Ben-Dov I
    Isr J Med Sci; 1994 Nov; 30(11):811-6. PubMed ID: 7982769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theophylline treatment of irreversible, chronic obstructive pulmonary disease].
    Iversen ET; Eiken PA; Nielsen LM; Laursen LC; Maltbaek N; Tønnesen FV; Rasmussen FV
    Ugeskr Laeger; 1994 Sep; 156(39):5696-9. PubMed ID: 7985256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease].
    Wang CH; Zhang Q; Li M; Fu PF; Yan ZM; Peng AM; Zhang GL
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):540-6. PubMed ID: 20367966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
    Giosue S; Bernocchi D; Parola D; Munno R; Mancini P
    J Int Med Res; 1987; 15(6):352-60. PubMed ID: 3325318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of theophylline on lung function and sleep in patients with severe chronic obstructive pulmonary disease].
    Li Y; Liu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):294-8. PubMed ID: 10374456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of theophylline in nonasthmatic airway obstruction.
    Schmidt R; Altschuler S
    Angiology; 1979 Nov; 30(11):744-9. PubMed ID: 389103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease.
    Mulloy E; McNicholas WT
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1030-6. PubMed ID: 8214921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of theophylline in the treatment of dyspnea in COPD.
    Mahler DA
    Chest; 1987 Jul; 92(1 Suppl):2S-6S. PubMed ID: 3297522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of theophylline on exercise performance in patients with severe chronic obstructive pulmonary disease.
    Fink G; Kaye C; Sulkes J; Gabbay U; Spitzer SA
    Thorax; 1994 Apr; 49(4):332-4. PubMed ID: 8202902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.